Transglutaminase 2 associated with PI3K and PTEN in a membrane-bound signalosome platform blunts cell death
Abstract Atypically expressed transglutaminase 2 (TG2) has been identified as a poor prognostic factor in a variety of cancers. In this study, we evaluated the contribution of TG2 to the prolonged cell survival of differentiated acute promyelocytic leukaemia (APL) cells in response to the standard t...
Main Authors: | Károly Jambrovics, Pál Botó, Attila Pap, Zsolt Sarang, Zsuzsanna Kolostyák, Zsolt Czimmerer, Istvan Szatmari, László Fésüs, Iván P. Uray, Zoltán Balajthy |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2023-03-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-023-05748-6 |
Similar Items
-
Transglutaminase 2 programs differentiating acute promyelocytic leukemia cells in all-trans retinoic acid treatment to inflammatory stage through NF-κB activation
by: Károly Jambrovics, et al.
Published: (2019-03-01) -
Transglutaminase 2 in human diseases
by: Szondy Zsuzsa, et al.
Published: (2017-09-01) -
Impaired Skeletal Muscle Development and Regeneration in Transglutaminase 2 Knockout Mice
by: Zsófia Budai, et al.
Published: (2021-11-01) -
The transcriptional control of the VEGFA-VEGFR1 (FLT1) axis in alternatively polarized murine and human macrophages
by: Apolka Domokos, et al.
Published: (2023-05-01) -
Genomic variants reveal differential evolutionary constraints on human transglutaminases and point towards unrecognized significance of transglutaminase 2.
by: Kiruphagaran Thangaraju, et al.
Published: (2017-01-01)